Table 1 Characteristics of the patients at baseline
Characteristic | Group I (N = 70 ) | Group II (N = 94) | p-value |
|---|---|---|---|
Age (years) | 62.51 ± 14.38 | 64.88 ± 16.00 | 0.33 |
Male/female, N (%) | 39/31 | 42/52 | 0.21 |
Time of from admission to ERCP (hour) | 44.07 ± 20.53 | 163.83 ± 65.60 | 0.00 |
Temperature (℃) | 36.86 ± 0.59 | 37.01 ± 0.82 | 0.11 |
Total bilirubin (umol/L) | 56.44 ± 48.02 | 41.63 ± 34.99 | 0.09 |
Direct bilirubin (umol/L) | 39.14 ± 38.64 | 27.34 ± 28.84 | 0.09 |
BMI (kg/m2) | 23.30 ± 2.17 | 23.38 ± 2.55 | 0.81 |
CRP (mg/L) | 29.46 ± 44.33 | 24.38 ± 33.47 | 0.43 |
WBC (U/L) | 11.01 ± 4.51 | 11.29 ± 4.18 | 0.18 |
PLT (U/L) | 215.10 ± 71.90 | 199.60 ± 65.68 | 0.09 |
Amylase (U/L) | 1534.13 ± 1502.45 | 1653.84 ± 1564.03 | 0.38 |
Creatine (U/L) | 70.62 ± 21.21 | 70.00 ± 33.61 | 0.99 |
ALT (U/L) | 220.11 ± 191.51 | 230.47 ± 219.35 | 0.73 |
AST U/L) | 245.53 ± 217.38 | 236.31 ± 260.62 | 0.86 |
ALP (U/L) | 176.17 ± 133.10 | 167.95 ± 136.14 | 0.74 |
γ-GT (U/L) | 324.02 ± 246.87 | 391.3 ± 326.18 | 0.18 |
BISAP | 1.02 ± 0.83 | 1.09 ± 0.86 | 0.72 |
Severity of AC | 0.86 | ||
Mild | 52 | 71 | |
Moderate | 18 | 23 | |
Lipase (U/L) | 605.03 ± 537.73 | 452.51 ± 395.14 | 0.26 |
Combines comorbid, N (%) | |||
Cardiovascular disease | 28 (40) | 35 (37.23) | 0.72 |
Diabetes mellitus | 10 (14.29) | 11 (11.70) | 0.62 |
COPD | 3 (4.29) | 3 (3.19) | 0.71 |
MT | 7 (10) | 3 (3.19) | 0.07 |
Others | 1 (1.43) | 3 (3.19 | 0.47 |
ASA(I/II/III/IV) | 10/42/17/1 | 12/61/21/0 | 0.65 |
Previous abdominal surgery, N (%) | 18(25.71) | 14 (14.89) | 0.08 |
Previous cholecystectomy, N (%) | 9 (12.86) | 5 (5.32) | 0.09 |
Previous ERCP, N (%) | 2 (2.86) | 2 (2.13) | 0.76 |